These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Use & mechanism of action of sulfonamide derivatives decreasing the blood sugar in insulin shock therapy in psychiatry]. BAYREUTHER H Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr; 1957; 195(5):435-45. PubMed ID: 13435855 [No Abstract] [Full Text] [Related]
24. [Oral treatment of diabetes mellitus with D-860, a new hypoglycemic but not sulfonamidic drug; clinical study of 90 cases]. INTROZZI P; MARIGO S Prog Med (Napoli); 1956 Sep; 12(17):513-27. PubMed ID: 13379550 [No Abstract] [Full Text] [Related]
25. [The effect of a hypoglycemic sulfonamide derivative (BZ 55) on the effectiveness of insulin in diabetics]. BARTELHEIMER H; MARING H Klin Wochenschr; 1956 Oct; 34(37-38):1011-6. PubMed ID: 13377627 [No Abstract] [Full Text] [Related]
26. Some clinical experiences with the arylsulfonylureas in the management of diabetes mellitus. ERK V; HAAR H; MCGAVACK TH; SEEGERS W Metabolism; 1956 Nov; 5(6 Part 2):919-32. PubMed ID: 13378061 [No Abstract] [Full Text] [Related]
27. Observations with sulfonylureas in diabetes. BROWN FR; FRISKEY RW; KINSELL LW; MICHAELS GD Metabolism; 1956 Nov; 5(6 Part 2):864-7. PubMed ID: 13378055 [No Abstract] [Full Text] [Related]
28. The use of orinase in diabetes. BEASER SB Metabolism; 1956 Nov; 5(6 Part 2):933-9. PubMed ID: 13378062 [No Abstract] [Full Text] [Related]
29. Metabolic studies with the arylsulfonylureas. KUHL WJ Metabolism; 1956 Nov; 5(6 Part 2):953-63. PubMed ID: 13378065 [No Abstract] [Full Text] [Related]
30. The treatment of diabetic patients with the sulphonamide BZ-55. LINEHAN WD; NASH J J Ir Med Assoc; 1956 Oct; 39(232):109-11. PubMed ID: 13367546 [No Abstract] [Full Text] [Related]
31. [Oral therapy of diabetes mellitus with invenol]. BLOCH J; LENHARDT A Wien Med Wochenschr; 1956 Jul; 106(27):594-8. PubMed ID: 13353170 [No Abstract] [Full Text] [Related]
32. Methods of selection of diabetic patients sensitive to sulfonylurea compounds. DUNCAN GG; JOINER CL; LEE CT Metabolism; 1956 Nov; 5(6 Part 2):964-71. PubMed ID: 13378066 [No Abstract] [Full Text] [Related]
33. [Resistance to oral Diabetes Therapy?]. ENGELHARD H Medizinische; 1956 Nov; 1(46):1639-41. PubMed ID: 13386741 [No Abstract] [Full Text] [Related]
34. [Experiences on 1,000 diabetics treated with sulfonylureas (BZ 55 and D 860)]. BERTRAM F Gaz Med Fr; 1957 Mar; 64(6):519-24. PubMed ID: 13427958 [No Abstract] [Full Text] [Related]
35. Clinical use of oral sulfonylurea compounds in diabetes mellitus. COLWELL AR; COLWELL JA Q Bull Northwest Univ Med Sch; 1957; 31(2):102-13. PubMed ID: 13453644 [No Abstract] [Full Text] [Related]
36. [Clinical evaluation of the hypoglycaemic action of BZ 55 (invenol)]. HERNANDEZ JAUREGUI R Medicina (Mex); 1957 Feb; 37(765):49-52. PubMed ID: 13407326 [No Abstract] [Full Text] [Related]
37. On the action of BZ-55 and D-860 in pancreatectomized dogs. SCHAMBYE P Diabetes; 1957; 6(2):146-50. PubMed ID: 13427619 [No Abstract] [Full Text] [Related]
38. Clinical experience with carbutamide and tolbutamide. COHN C; HEINEMAN A; LEVINE R; WEINSTEIN M Metabolism; 1956 Nov; 5(6 Part 2):972-7. PubMed ID: 13378067 [No Abstract] [Full Text] [Related]
39. [Usefulness of blood sugar decreasing sulfonamides for insulin shock treatment in psychiatry]. BAYREUTHER H; SPECHT N Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr; 1956; 195(2):132-9. PubMed ID: 13382306 [No Abstract] [Full Text] [Related]
40. Diabetes mellitus. BERNHARD H Indian J Med Sci; 1957 Feb; 11(2):59-63. PubMed ID: 13428303 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]